Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, drug interactions, and role in therapy of vildagliptin for the treatment of type 2 diabetes mellitus were reviewed.

Objective: We sought to evaluate the efficacy and safety of vildagliptin, a new dipeptidyl peptidase-4 inhibitor, added to metformin during 24 weeks of treatment in patients with type 2 diabetes.

New Delhi: In its latest drug alert, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), ...

Through a letter, the Hind Institute of Medical Sciences (HIMS) has notified regarding charging less tuition fees for ...

The 15 medicines included in the initiative include three branded medicines: valsartan for hypertension; vildagliptin for diabetes and breast cancer therapy letrozole (breast cancer). It also ...

The firm already markets recently-approved Entresto (sacubitril+valsartan) to treat heart failure, and diabetes drug Galvus (vildagliptin) through its cardio-metabolic division, and is looking to ...

It launched a combination drug Vildanat M (Vildagliptin and Metformin) for diabetes, to achieve better blood glucose control and improve therapy compliance.During the period 2019-20, NATCO Life ...

Inhibitors of the enzyme DPP-4, such as sitagliptin, lower blood sugar while being safe and tolerable. Vildagliptin and alogliptin were well tolerated and showed excellent safety profiles. The drugs ...

You are free to share (copy and redistribute) this article in any medium or format and to adapt (remix, transform, and build upon) the material for any purpose, even commercially within the parameters ...